NCT01236235 Study on Long Term Outcomes of Atazanavir in Antiretroviral-naïve Human Immunodeficiency Virus (HIV) Patients in Real Life Setting Status COMPLETED Phase N/A
NCT01233531 Effects of Cash Transfer for the Prevention of HIV in Young South African Women Status COMPLETED Phase PHASE3
NCT01232361 IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and Adolescents Status COMPLETED Phase N/A
NCT01232127 Effects of Famotidine on the Pharmacokinetics of Atazanavir When Coadministered to Participants With HIV Infection Status COMPLETED Phase PHASE4
NCT01231685 Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection Status COMPLETED Phase PHASE2
NCT01225705 Safety Study of Raltegravir in HIV/HCV Co-infected Patients Status WITHDRAWN Phase PHASE4
NCT01214759 Truvada Plus Raltegravir for Nonoccupational Post-exposure Prophylaxis (nPEP) Status COMPLETED Phase PHASE4
NCT01214486 Measurement of Plasma and Intracellular Concentrations of Raltegravir Status COMPLETED Phase NA
NCT01212042 Multiplex Microarray Chip-Based Diagnosis of Respiratory Infections Status TERMINATED Phase N/A
NCT01205581 Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV Status COMPLETED Phase PHASE2
NCT01203332 Identifying Undiagnosed Asymptomatic HIV Infection in Hispanic/Latino Adolescents and Young Adults Status COMPLETED Phase N/A
NCT01202305 The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies Status RECRUITING Phase N/A
NCT01201239 Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients Status UNKNOWN Phase PHASE4